Search Results

131 items found for " Jinbong Park"

Posts (80)

C1-inhibitor influence on platelet activation by thrombin receptors agonists
September 2022 "Introduction Protease activated receptors 1 (PAR1) and 4 (PAR4) agonists are used to Here we show that C1INH affects platelet activation through PAR1 and PAR4 agonists. The platelet suspensions were exposed to PAR1 agonists SFLLRN, TFLLR and TFLLRN; PAR4 agonists AYPGKF
GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP
October 2022 "Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor (GPCR) activated by of PAR2 that induces unique cellular signaling, distinct from trypsin and PAR2-activating peptide (AP Interestingly, unlike PAR2-AP, GB83 and trypsin induced sustained receptor endocytosis and PAR2 colocalization by GB83, which may be the reason why GB83 is recognized as an antagonist of PAR2. Our results revealed that GB83 is a bona fide agonist of PAR2 that uniquely modulates PAR2-mediated cellular
Mark Schmeizl - Dr. GPCR Podcast
Our guest is Mark Schmeizl!

DANGER Signals Activate G-Protein Receptor Kinases Suppressing Neutrophil Function and Predisposing to Infection After Tissue Trauma
repository PMN showed GRK2 activation and cortactin deacetylation which varied with severity and was most marked Authors Hyo In Kim , Jinbong Park , David Gallo , Sidharth Shankar , Barbora Konecna , Yohan Han , Valerie
GPCR Retreat 2023 - Part I
Keith Parker to elucidate the role of steroidogenesis in regulating sexual determination and adrenal
Ep 55 with Mark Schmeizl
GPCR Podcast << Back to podcast list Mark Schmeizl About Mark Schmeizl Mark leverages 30 years in various Mark believes professional placement should be about matching talented people with companies where they Mark Schmeizl on the web Website LinkedIn Dr.